Antimicrobial resistance (AMR) has emerged as one of the most serious public health challenges of the 21st century. AMR occurs when microorganisms such as bacteria, viruses, fungi, and parasites no longer respond effectively to antimicrobial medicines, making infections difficult to treat and increasing the risk of prolonged illness, complications, transmission, and death [1]. Although resistance is a natural biological phenomenon, its rapid acceleration is largely driven by human-related factors such as inappropriate antibiotic prescribing, self-medication, incomplete treatment courses, over-the-counter availability of antibiotics, poor infection control practices, and excessive antimicrobial use in agriculture and animal husbandry [2,3].

The global burden of AMR is substantial. The Global Research on Antimicrobial Resistance study estimated that bacterial AMR was associated with approximately 4.95 million deaths in 2019, including 1.27 million deaths directly attributable to resistant bacterial infections [4]. This burden is particularly high in low- and middle-income countries, where overcrowding, limited diagnostic facilities, inadequate sanitation, weak antimicrobial stewardship, and restricted access to quality healthcare contribute to the spread of resistant organisms [5]. AMR also threatens the success of modern medical care, including surgery, intensive care, organ transplantation, cancer chemotherapy, neonatal care, and management of chronic diseases, where effective antimicrobial therapy is essential for preventing and treating infections [6].

The consequences of AMR extend beyond clinical failure. Resistant infections often require longer hospital stays, use of expensive second-line or reserve antibiotics, repeated investigations, and increased healthcare expenditure [7]. At the community level, AMR increases disease transmission and reduces the effectiveness of standard treatment protocols, while at the national and global level, it affects productivity, health system resilience, and economic development [8]. The problem is further complicated by the slow development of new antibiotics and the limited availability of novel antimicrobial agents, creating a widening gap between emerging resistance and therapeutic options [9].

Prevention of AMR requires a coordinated One Health approach involving human health, animal health, agriculture, and environmental sectors. Key strategies include rational antibiotic prescribing, antimicrobial stewardship programs, strengthening laboratory-based surveillance, infection prevention and control, vaccination, improved sanitation, regulation of antibiotic sales, public awareness, and promotion of research into new antimicrobials and diagnostics [1,10]. Therefore, this narrative review aims to discuss the major causes, consequences, and prevention strategies of antimicrobial resistance, with emphasis on its clinical and public health relevance.

This narrative review aims to comprehensively explore antimicrobial resistance (AMR) by analyzing its underlying causes, clinical and public health consequences, and evidence-based prevention strategies, with the objective of synthesizing current global and regional literature to highlight key drivers such as irrational antimicrobial use, inadequate infection control, and gaps in stewardship practices, while also identifying effective interventions including antimicrobial stewardship programs, surveillance systems, vaccination, and policy-level regulations. The justification for this review lies in the rapidly escalating burden of AMR, which threatens the effectiveness of existing therapies, increases morbidity, mortality, and healthcare costs, and poses a significant challenge to achieving sustainable healthcare outcomes, particularly in low- and middle-income settings like India where misuse of antibiotics and limited regulatory control are prevalent. Furthermore, this review is expected to provide future outcomes by offering a consolidated understanding that can guide clinicians, public health professionals, and policymakers in designing targeted interventions, strengthening antimicrobial stewardship, promoting rational drug use, and enhancing awareness, ultimately contributing to reduced resistance rates, improved patient outcomes, and preservation of antimicrobial efficacy for future generations.

METHODOLOGY

This narrative review was conducted to synthesize existing evidence on antimicrobial resistance (AMR), focusing on its causes, consequences, and prevention strategies. A comprehensive literature search was carried out using electronic databases including PubMed, Google Scholar, Scopus, and Web of Science. Relevant articles published in English from 2010 to 2025 were identified using a combination of keywords and MeSH terms such as “antimicrobial resistance,” “antibiotic resistance,” “causes,” “risk factors,” “consequences,” “public health impact,” “antimicrobial stewardship,” and “prevention strategies.” Additional sources such as reports from international organizations including the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and World Bank were also included to ensure incorporation of global perspectives and policy frameworks.

The literature search initially identified 312 records from electronic databases (PubMed, Google Scholar, Scopus, and Web of Science) and institutional reports. After removal of 52 duplicate records, a total of 260 studies were screened based on titles and abstracts. During the screening phase, 170 articles were excluded due to irrelevance to antimicrobial resistance, leaving 90 articles for full-text assessment. Of these, 55 studies were excluded as they did not meet inclusion criteria (non-relevant outcomes, insufficient data, or lack of methodological clarity). Finally, 35 studies were included in the narrative review and were systematically analyzed under thematic domains of causes, consequences, and prevention strategies of antimicrobial resistance.

Studies were selected based on their relevance to the topic, including original research articles, systematic reviews, meta-analyses, and policy reports that addressed determinants, clinical and economic impact, and strategies for prevention and control of AMR. Articles focusing on unrelated topics, non-human studies without public health relevance, or those lacking sufficient methodological clarity were excluded. The selected literature was critically reviewed and categorized into thematic areas, including causes of AMR, clinical and economic consequences, and prevention strategies. Data were synthesized qualitatively, and findings were presented in a descriptive manner to provide a comprehensive overview of the current understanding of AMR. Efforts were made to include both global and Indian perspectives to enhance contextual relevance.

Thematic Analysis of Antimicrobial Resistance (AMR)

Theme 1: Irrational Use and Overuse of Antimicrobials

“Irrational prescribing practices and widespread misuse of antibiotics remain the most significant drivers of antimicrobial resistance globally” (Llor& Bjerrum, 2014) [11]. In both community and hospital settings, antibiotics are frequently prescribed for viral infections, inappropriate indications, or without microbiological confirmation. Studies indicate that nearly 50% of antibiotic prescriptions are inappropriate, particularly in outpatient care [12]. In low- and middle-income countries, including India, over-the-counter availability and self-medication further exacerbate the problem, with reports suggesting that up to 60% of individuals consume antibiotics without prescription [13]. Additionally, incomplete treatment courses and use of substandard or counterfeit drugs contribute to the selection of resistant strains. This misuse not only accelerates resistance but also reduces the effectiveness of standard treatment regimens, leading to increased therapeutic failure rates.

Theme 2: Hospital-Acquired Infections and Poor Infection Control Practices

“Healthcare-associated infections significantly contribute to the emergence and spread of multidrug-resistant organisms due to inadequate infection prevention measures” (Allegranzi et al., 2011) [14]. Hospitals act as critical reservoirs for resistant pathogens such as Acinetobacter baumannii, Pseudomonas aeruginosa, and MRSA. Data suggest that 7–10% of hospitalized patients globally acquire healthcare-associated infections, with a higher prevalence in developing countries [15]. Inadequate hand hygiene, improper sterilization, overcrowding, and prolonged hospital stays increase the transmission of resistant organisms. Intensive care units (ICUs) are particularly high-risk areas, where the use of invasive devices like ventilators and catheters further predisposes patients to infections. Poor antimicrobial stewardship in hospitals leads to excessive use of broad-spectrum antibiotics, further driving resistance patterns.

Theme 3: Use of Antibiotics in Agriculture and Animal Husbandry

“The extensive use of antimicrobials in livestock for growth promotion and disease prevention has contributed significantly to the development of resistant strains transferable to humans” (Van Boeckel et al., 2015) [16]. Globally, it is estimated that over 70% of medically important antibiotics are used in animals, often without veterinary supervision. These antibiotics enter the human food chain through meat, milk, and environmental contamination. Studies have shown increasing resistance in zoonotic pathogens such as Salmonella and Campylobacter, posing a significant public health risk. In India, the lack of strict regulatory policies and monitoring systems has led to indiscriminate use of antibiotics in poultry and dairy farming. Environmental contamination through agricultural runoff further facilitates the spread of resistant genes in soil and water systems.

Theme 4: Clinical and Economic Consequences of AMR

“Antimicrobial resistance leads to increased morbidity, mortality, prolonged hospital stays, and substantial economic burden on healthcare systems” (Prestinaci et al., 2015) [17]. Resistant infections are associated with higher mortality rates (up to 2–3 times greater) compared to susceptible infections. Patients with resistant infections often require second-line or reserve antibiotics, which are more expensive and less accessible. Studies estimate that AMR could result in 10 million deaths annually by 2050 if no effective interventions are implemented. Economically, AMR increases healthcare costs due to longer hospitalization, additional diagnostic tests, and intensive care requirements. In India, the financial burden is particularly significant due to high out-of-pocket expenditure, making treatment unaffordable for many patients.

Theme 5: Prevention Strategies and Antimicrobial Stewardship

“Effective antimicrobial stewardship programs, along with infection control measures and public awareness, are essential to combat antimicrobial resistance” (Dyar et al., 2017) [11–17]. Prevention strategies include rational prescribing, adherence to treatment guidelines, and restriction of over-the-counter antibiotic sales. Implementation of antimicrobial stewardship programs has been shown to reduce antibiotic use by 20–30% without compromising patient outcomes. Vaccination programs, improved sanitation, and public education play a critical role in reducing infection rates and subsequent antibiotic demand. Strengthening laboratory surveillance systems enables early detection of resistance patterns and guides appropriate therapy. A “One Health” approach integrating human, animal, and environmental health sectors is essential for comprehensive AMR control. Policy-level interventions, including strict regulation of antibiotic use in agriculture and promotion of research into new antimicrobials, are also crucial for long-term sustainability.

Table 1: Thematic Summary of Antimicrobial Resistance

DISCUSSION

“Antimicrobial resistance (AMR) has evolved into a complex, multifactorial global health crisis driven by interconnected clinical, behavioral, and environmental determinants” (World Health Organization, 2023) [1]. The present narrative synthesis highlights that irrational antimicrobial use, inadequate infection control, agricultural misuse, and weak policy implementation collectively contribute to the accelerating burden of resistance. Consistent with earlier global analyses, inappropriate antibiotic prescribing remains a dominant factor, with studies reporting that nearly half of antimicrobial prescriptions lack appropriate indication or duration, particularly in outpatient and primary care settings [2,11,12]. This issue is further compounded in developing countries by over-the-counter availability and self-medication practices, which have been documented in up to 60% of antibiotic users, reinforcing the selective pressure for resistant organisms [3,13].

The findings also emphasize the critical role of healthcare settings in amplifying AMR. “Healthcare-associated infections (HAIs) serve as major reservoirs for multidrug-resistant organisms due to lapses in infection prevention and control measures” (Allegranzi et al., 2011) [14]. The prevalence of HAIs, estimated at 7–10% globally, is significantly higher in resource-limited settings, reflecting disparities in infrastructure, staffing, and adherence to standard precautions [5,15]. In intensive care units, excessive use of broad-spectrum antibiotics and invasive procedures further increases the risk of colonization and infection with resistant pathogens. Similar observations have been reported in Indian tertiary care centers, where high rates of carbapenem resistance among Acinetobacter and Pseudomonas species have been documented, highlighting the urgent need for robust antimicrobial stewardship programs [6].

Another important dimension identified in this review is the contribution of non-human antimicrobial use. “The widespread use of antibiotics in agriculture and animal husbandry significantly contributes to the emergence of resistant strains that can be transmitted to humans” (Van Boeckel et al., 2015) [16]. The fact that more than 70% of global antibiotic consumption occurs in the animal sector underscores the magnitude of this issue. Environmental dissemination through food chains, water systems, and soil contamination facilitates horizontal gene transfer, thereby accelerating the spread of resistance across species and ecosystems. This supports the growing consensus that AMR cannot be addressed solely within clinical settings and requires a comprehensive One Health approach integrating human, animal, and environmental health sectors [10].

The clinical and economic consequences of AMR are profound and far-reaching. “Resistant infections are associated with significantly higher morbidity, mortality, and healthcare costs compared to susceptible infections” (Prestinaci et al., 2015) [17]. The Global Burden of Disease study further quantified this impact, attributing approximately 1.27 million deaths directly to AMR in 2019, with a total of 4.95 million deaths associated with resistant infections [4]. Patients with resistant infections often require prolonged hospitalization, advanced supportive care, and expensive second-line therapies, which increases the economic burden on both healthcare systems and individuals. In countries like India, where out-of-pocket expenditure constitutes a major proportion of healthcare spending, AMR exacerbates financial hardship and limits access to effective treatment [8].

Encouragingly, the review also highlights that targeted interventions can significantly mitigate the burden of AMR. “Antimicrobial stewardship programs have been shown to reduce inappropriate antibiotic use by up to 20–30% without adversely affecting clinical outcomes” (Dyar et al., 2017) [11–17]. Strengthening infection prevention practices, promoting vaccination, ensuring rational prescribing, and improving diagnostic capacity are key components of AMR control strategies. Additionally, public awareness campaigns and regulatory measures restricting over-the-counter antibiotic sales have demonstrated effectiveness in reducing misuse. Recent evidence further suggests that integrated surveillance systems and digital health interventions can enhance early detection of resistance patterns and optimize treatment decisions, thereby improving patient outcomes (Holmes et al., 2016) [18].

From a policy perspective, global and national initiatives such as the WHO Global Action Plan and national antimicrobial resistance programs have laid the foundation for coordinated efforts to tackle AMR [5,10]. However, implementation gaps remain a significant challenge, particularly in low- and middle-income countries. “Sustained political commitment, intersectoral collaboration, and investment in research and development are essential to address the growing threat of antimicrobial resistance” (O’Neill, 2016) [7,19]. Furthermore, the development of new antibiotics, alternative therapies, and rapid diagnostic tools is critical to bridge the widening gap between emerging resistance and available treatment options. Recent studies also emphasize the importance of behavioral interventions targeting prescribers and patients to promote rational antimicrobial use (Fleming-Dutra et al., 2016) [20].

In summary, AMR represents a dynamic and escalating challenge that threatens the effectiveness of modern medicine. The findings of this review underscore the need for a multifaceted approach combining clinical, public health, and policy-level interventions. Strengthening antimicrobial stewardship, enhancing surveillance, regulating antibiotic use across sectors, and fostering global collaboration are essential to curb the spread of resistance and preserve the efficacy of existing antimicrobial agents for future generations.

CONCLUSION

“Antimicrobial resistance (AMR) represents a rapidly escalating global health threat that undermines the effectiveness of existing therapeutic interventions and challenges modern healthcare systems”. This narrative review demonstrates that AMR is driven by a complex interplay of factors, including irrational antimicrobial use, inadequate infection prevention and control, widespread use of antibiotics in agriculture, and insufficient regulatory frameworks. The consequences are profound, with increased morbidity, mortality, prolonged hospital stays, and significant economic burden on both individuals and healthcare systems. Importantly, the findings highlight that AMR is not solely a clinical issue but a broader public health and developmental concern requiring a coordinated, multisectoral response. Strengthening antimicrobial stewardship, improving surveillance systems, enforcing regulatory measures, and promoting a One Health approach are essential to mitigate the spread of resistance and preserve the efficacy of existing antimicrobials for future generations.

LIMITATIONS

• This study is a narrative review, and therefore lacks the methodological rigor of systematic reviews or meta-analyses.
• Selection of studies may be subject to selection bias, as inclusion was based on relevance rather than strict predefined criteria.
• The review included only English-language publications, which may have led to exclusion of relevant data from other languages.
• Quantitative synthesis and statistical analysis were not performed, limiting the ability to derive pooled estimates.
• Variability in study design, population, and outcome measures across included studies may affect comparability of findings.
• Limited availability of region-specific (especially Gujarat-based) data restricted localized interpretation.

Recommendations

• Strengthen Antimicrobial Stewardship Programs (ASP): Implement strict guidelines for rational antibiotic prescribing in both hospital and community settings.
• Enhance Infection Prevention and Control (IPC): Promote hand hygiene, sterilization protocols, and surveillance of healthcare-associated infections.
• Regulate Antibiotic Use: Enforce policies to restrict over-the-counter sale of antibiotics and regulate their use in agriculture and animal husbandry.
• Improve Surveillance Systems: Establish robust national and regional AMR surveillance networks for early detection and monitoring of resistance trends.
• Promote Public Awareness: Conduct health education campaigns to reduce self-medication and improve adherence to prescribed treatments.
• Encourage Research and Development: Invest in the development of new antimicrobials, vaccines, and rapid diagnostic tools.
• Adopt One Health Approach: Integrate human, animal, and environmental health strategies to comprehensively address AMR.
• Strengthen Policy Implementation: Ensure effective execution of national and global AMR action plans with sustained political commitment.

REFERENCES

1. World Health Organization. Antimicrobial resistance. Geneva: WHO; 2023.
2. Michael CA, Dominey-Howes D, Labbate M. The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health. 2014;2:145.
3. Habboush Y, Guzman N. Antibiotic resistance. Treasure Island: StatPearls Publishing; 2023.
4. Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655.
5. World Health Organization. Global action plan on antimicrobial resistance. Geneva: WHO; 2015.
6. Centers for Disease Control and Prevention. About antimicrobial resistance. Atlanta: CDC; 2025.
7. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. London: Review on Antimicrobial Resistance; 2016.
8. World Bank. Drug-resistant infections: a threat to our economic future. Washington DC: World Bank; 2017.
9. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277–283.
10. Interagency Coordination Group on Antimicrobial Resistance. No time to wait: securing the future from drug-resistant infections. Geneva: WHO; 2019.
11. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229–241.
12. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277–283.
13. Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6:47.
14. Allegranzi B, Bagheri Nejad S, Combescure C, et al. Burden of endemic healthcare-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228–241.
15. World Health Organization. Report on the burden of endemic health care-associated infection worldwide. Geneva: WHO; 2011.
16. Van Boeckel TP, Brower C, Gilbert M, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci U S A. 2015;112(18):5649–5654.
17. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309–318.
18. Holmes AH, Moore LSP, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176–187.
19. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. London: Review on Antimicrobial Resistance; 2016.
20. Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits. JAMA. 2016;315(17):1864–1873.